Compared with other treatments, CD73 expressed by ERCs protected against systemic exposure to FITC-dextran after intraperitoneal administration in DSS-induced colitis mice (Figure 3D, P < 0.0001), suggesting the restoration of intestinal permeability. Here, NT5E is linked to colitis.